ANAB - ANAPTYSBIO, INC
IEX Last Trade
13.97
0.120 0.859%
Share volume: 8,658
Last Updated: Thu 26 Dec 2024 08:29:29 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$13.85
0.12
0.87%
Summary score
14%
Profitability
8%
Dept financing
18%
Liquidity
75%
Performance
4%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.76%
Return on assets
-4.72%
Return on sales
-1282.81%
Return on invested capital
982.63%
Total debt ratio
42.07%
Debt ratio change over timeo
-1.82%
Current Ratio
18.47%
Quick Ratio
18.43%
Cash Position Ratio
17.62%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-49.43%
Return on assets
-8.4%
Return on sales
-817.91%
Return on invested capital
-1186.7%
Total debt ratio
78.84%
Debt ratio change over timeo
-1.31%
Current Ratio
10.96%
Quick Ratio
10.96%
Cash Position Ratio
10.57%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-91.96%
Return on assets
-10.4%
Return on sales
-587.84%
Return on invested capital
-3933.39%
Total debt ratio
88.23%
Debt ratio change over time
-1.17%
Current Ratio
11.53%
Quick Ratio
11.53%
Cash Position Ratio
10.98%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-74.15%
Return on assets
-85.91%
Return on sales
3274.01%
Return on invested capital
-212.95%
Total debt ratio
-182.2%
Debt ratio change over time
-1.82%
Current Ratio
-68.01%
Quick Ratio
-67.87%
Cash Position Ratio
-65.07%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | ANAB | ABBV | AMGN | REGN |
---|---|---|---|---|
Return on equity | -17.76% | 13.79% | 34.47% | 7.43% |
Return on assets | -4.72% | 2.76% | 3.15% | 5.62% |
Return on sales | -1282.81% | 28.74% | 32.53% | 40.48% |
Return on invested capital | 982.63% | 2.36% | 5.39% | 19.77% |
Profitability | 25% | 40% | 59% | 56% |
Total debt ratio | 42.07% | 90.46% | 90.54% | 26.74% |
Debt ratio change over time | -1.82% | 308.97% | -6.99% | 1.18% |
Dept financing | 12% | 50% | 25% | 7% |
Current Ratio | 10.96% | 0.91% | 2.18% | 5.4% |
Quick Ratio | 10.96% | 0.8% | 1.79% | 4.64% |
Cash Position Ratio | 10.57% | 0.36% | 1.28% | 2.93% |
Liquididy | 75% | 3% | 6% | 14% |
Short-term ratios | ANAB | ABBV | AMGN | REGN |
---|---|---|---|---|
Return on equity | -49.43% | 13.77% | 13.25% | 3.8% |
Return on assets | -8.4% | 2.43% | 1.89% | 3.09% |
Return on sales | -817.91% | 24.64% | 23.72% | 30.49% |
Return on invested capital | -1186.7% | 2.14% | 3.39% | 9.18% |
Profitability | 0% | 71% | 68% | 82% |
Total debt ratio | 78.84% | 92.14% | 93.05% | 21.79% |
Debt ratio change over time | -1.31% | 46.38% | -72.08% | 1.51% |
Dept financing | 21% | 50% | 25% | 7% |
Current Ratio | 10.96% | 0.91% | 2.18% | 5.4% |
Quick Ratio | 10.96% | 0.8% | 1.79% | 4.64% |
Cash Position Ratio | 10.57% | 0.36% | 1.28% | 2.93% |
Liquididy | 75% | 5% | 12% | 30% |